Bristol-Myers Squibb Co.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2017
Total Assets: $33.55B
Liabilities Breakdown FY2017
Total Liabilities: $21.70B
Asset Breakdown
Total Assets: $33.55B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $5.42B | 16.2% |
| Accounts Receivable | $4.35B | 13.0% |
| Inventory | $1.17B | 3.5% |
| Property, Plant & Equipment | $5.00B | 14.9% |
| Goodwill | $6.86B | 20.5% |
| Intangible Assets | $1.21B | 3.6% |
| Other Assets | $9.54B | 28.4% |
Liabilities Breakdown
Total Liabilities: $21.70B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.25B | 10.4% |
| Long-Term Debt | $6.98B | 32.1% |
| Other Liabilities | $12.48B | 57.5% |